NCT07069972View on ClinicalTrials.gov

A Prospective Comparative Study Involving Multiple Units to Evaluate the Efficacy and Safety of Telitacicept and Belimumab in the Treatment of Systemic Lupus Erythematosus.

Not yet recruitingOBSERVATIONAL

Enrollment

180

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2028

Conditions

Systemic Lupus Erythematosus

Trial Locations (1)

250000

Qianfoshan Hospital, Jinan

All Listed Sponsors

collaborator

Renmin Hospital of Wuhan University

OTHER

collaborator

Affiliated Hospital of Shandong University of Traditional Chinese Medicine

OTHER

lead

Yipeng Liu

OTHER

NCT07069972 - A Prospective Comparative Study Involving Multiple Units to Evaluate the Efficacy and Safety of Telitacicept and Belimumab in the Treatment of Systemic Lupus Erythematosus. | Biotech Hunter | Biotech Hunter